{"id":"W51594977","doi":"10.14694/edbook_am.2012.32.197","title":"Establishing the Standard of Care for Patients with Newly Diagnosed and Recurrent Glioblastoma","year":2012,"lang":"en","type":"article","venue":"American Society of Clinical Oncology Educational Book","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Temozolomide; Medicine; Bevacizumab; Oncology; Clinical trial; Randomized controlled trial; Internal medicine; Adjuvant; Dacarbazine; Standard of care; Dosing; Cancer; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004132596,0.0003231924,0.0008028655,0.0007443676,0.00107586,0.001702531,0.001447418,0.00188228,0.001746137],"category_scores_gemma":[0.01357362,0.0001600221,0.0005945069,0.0005303099,0.0006997581,0.001522414,0.002232438,0.002925086,0.001513694],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002682422,"about_ca_system_score_gemma":0.006520373,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002907053,"about_ca_topic_score_gemma":0.004734908,"domain_scores_codex":[0.996414,0.001160464,0.0006160347,0.0003348794,0.001169622,0.0003050553],"domain_scores_gemma":[0.9954301,0.0004488881,0.0008551939,0.0002702692,0.002101973,0.00089348],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004925011,0.0005607732,0.03611785,0.0006649754,0.000113426,0.001369546,0.0005407027,0.001434919,0.003757194,0.009318404,0.1918884,0.7537413],"study_design_scores_gemma":[0.0008733179,0.00278152,0.1527652,0.00462312,0.000315195,0.007757512,0.002064019,0.007124698,0.006052474,0.03336155,0.7820512,0.0002301739],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.1217003,0.09722815,0.133181,0.5152468,0.01055393,0.007025603,0.001739478,0.002154613,0.11117],"genre_scores_gemma":[0.6532288,0.04758423,0.1650374,0.1037149,0.00841133,0.005318456,0.004681911,0.0003269278,0.01169599],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.004132596,"threshold_uncertainty_score":0.02185553,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02842049355554417,"score_gpt":0.3951774383224095,"score_spread":0.3667569447668653,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}